Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-24-016162

EVP, Chief Financial Officer acquired 4,439 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DArecca James EVP, Chief Financial Officer 2024-05-17 Grant or award +4,439 17,346 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
DArecca James EVP, Chief Financial Officer 2024-05-17 Grant or award · Non-qualified Stock Option (Right to Buy) +9,756 9,756 D: show line 2 in the form
Loading xslF345X05/form4.xml…